Literature DB >> 16438481

A look between the cardiomyocytes: the extracellular matrix in heart failure.

Edward C Miner1, Wayne L Miller.   

Abstract

The extracellular matrix (ECM) of the heart dynamically interacts with various cellular components of the myocardium, including the myocytes and connective tissue cells. With the development and progression of heart failure, left ventricular (LV) myocardial remodeling occurs. The progression of LV remodeling is accompanied by alterations in the structure and function of the ECM that occur after injury resulting from neurohormonal activation, changes in LV loading conditions, and alterations in myocardial perfusion and metabolism and is secondary to a host of nonmyocyte signaling pathways that affect repair and remodeling of the myocardium as a whole. This article attempts to review some of these processes and their interactions and to provide a focus to the often overlooked contribution of the ECM to the development and progression of heart failure and thereby its potential role as a target for therapy for heart failure.

Entities:  

Mesh:

Year:  2006        PMID: 16438481     DOI: 10.4065/81.1.71

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  25 in total

1.  Osteopontin-stimulated expression of matrix metalloproteinase-9 causes cardiomyopathy in the mdx model of Duchenne muscular dystrophy.

Authors:  Saurabh Dahiya; Srikanth Givvimani; Shephali Bhatnagar; Natia Qipshidze; Suresh C Tyagi; Ashok Kumar
Journal:  J Immunol       Date:  2011-08-01       Impact factor: 5.422

Review 2.  Micro- and nanoscale control of the cardiac stem cell niche for tissue fabrication.

Authors:  Bari Murtuza; Jason W Nichol; Ali Khademhosseini
Journal:  Tissue Eng Part B Rev       Date:  2009-12       Impact factor: 6.389

3.  Scleraxis is required for cell lineage differentiation and extracellular matrix remodeling during murine heart valve formation in vivo.

Authors:  Agata K Levay; Jacqueline D Peacock; Yinhui Lu; Manuel Koch; Robert B Hinton; Karl E Kadler; Joy Lincoln
Journal:  Circ Res       Date:  2008-09-18       Impact factor: 17.367

4.  Increased connective tissue growth factor associated with cardiac fibrosis in the mdx mouse model of dystrophic cardiomyopathy.

Authors:  Carol G Au; Tanya L Butler; Megan C Sherwood; Jonathan R Egan; Kathryn N North; David S Winlaw
Journal:  Int J Exp Pathol       Date:  2010-12-01       Impact factor: 1.925

5.  Bosentan attenuates right ventricular hypertrophy and fibrosis in normobaric hypoxia model of pulmonary hypertension.

Authors:  Gaurav Choudhary; Frederick Troncales; Douglas Martin; Elizabeth O Harrington; James R Klinger
Journal:  J Heart Lung Transplant       Date:  2011-05-08       Impact factor: 10.247

6.  Obesity and preclinical changes of cardiac geometry and function.

Authors:  Joong Kyung Sung; Jang-Young Kim
Journal:  Korean Circ J       Date:  2010-02-23       Impact factor: 3.243

Review 7.  Natural ECM as biomaterial for scaffold based cardiac regeneration using adult bone marrow derived stem cells.

Authors:  P Sreejit; R S Verma
Journal:  Stem Cell Rev Rep       Date:  2013-04       Impact factor: 5.739

8.  Effect of matrix on cardiomyocyte viscoelastic properties in 2D culture.

Authors:  Sandra Deitch; Bruce Z Gao; Delphine Dean
Journal:  Mol Cell Biomech       Date:  2012-09

Review 9.  Fibrosis and heart failure.

Authors:  Ana Maria Segura; O H Frazier; L Maximilian Buja
Journal:  Heart Fail Rev       Date:  2014-03       Impact factor: 4.214

10.  Physiologic and molecular characterization of a murine model of right ventricular volume overload.

Authors:  Sushma Reddy; Mingming Zhao; Dong-Qing Hu; Giovanni Fajardo; Ethan Katznelson; Rajesh Punn; Joshua M Spin; Frandics P Chan; Daniel Bernstein
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-03-15       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.